TXMD Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 03, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for TherapeuticsMD Inc (TXMD)

Based on 6 analysts giving stock ratings to TherapeuticsMD Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
0
Buy
0
Hold
50
Sell
17
Strong Sell
33
TherapeuticsMD Inc

TherapeuticsMD Inc. Stock Analysis TXMD

United States Health Care Nano Cap Report:
TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 1 full-time employees. The company went IPO on 2001-01-31. The company receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
Read More

TherapeuticsMD Inc (TXMD) Chart

Key Statistics of TherapeuticsMD Inc (TXMD)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.00$2.05

Today's Open

$2.00

Volume

9915.00

P/E Ratio (TTM)

-

52 Week Range

$0.98$2.95

Market Cap

23.96M

Avg. Volume

25.10K

Dividend Yield

-

Financial Metrics & Statements of TherapeuticsMD Inc (TXMD)

FAQ's for TherapeuticsMD Inc (TXMD)

  • According to Musaffa’s Shariah screening methodology, TherapeuticsMD Inc (TXMD) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.